Publications
Filters: Author is Russo, P [Clear All Filters]
A system for the extraction and representation of summary of product characteristics content. Artificial Intelligence in Medicine. 2013;57(2):145-54.
A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis. Haematologica. 2013;98(3):433-6.
Nutritional status independently affects quality of life of patients with systemic immunoglobulin light-chain (AL) amyloidosis. Annals of Hematology. 2012;91(3):399-406.
Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide. Annals of Hematology. 2012;91(1):89-92.
Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure. American Journal of Hematology. 2012;87(5):465-71.
Developing an eLearning tool formalizing in YAWL the guidelines used in a transfusion medicine service. Studies in Health Technology and Informatics. 2012;180:1168-70.
Advanced ICT Improved the Research and Treatment Quality for a Rare Disease: the Italian Amyloidosis Network Experience.; 2011. (23rd International Conference of the European Federation for Medical Informatics (MIE 2011)).
Treatment of IgM-Associated AL Amyloidosis With the Combination of Rituximab, Bortezomib, and Dexamethasone. Clinical Lymphoma Myeloma and Leukemia. 2011;11(1):143-5.
Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosis. Amyloid. 2011;18(4):216-21.
Advanced ICT Improved the Research and Treatment Quality for a Rare Disease: the Italian Amyloidosis .; 2011. (Network Tools and Applications in Biology Workshop on Clinical Bioinformatics (NETTAB 2011)).
An Ontology-based Decision Support System for the Diagnosis of Systemic Amyloidosis.; 2011. (Network Tools and Applications in Biology Workshop on Clinical Bioinformatics (NETTAB 2011)).
The Pavia Project for the Integration of Clinical Data with a Centralized Biobank for Systemic Amyloidosis.; 2011. (Network Tools and Applications in Biology Workshop on Clinical Bioinformatics (NETTAB 2011)).
AMICA: an electronic patient record specifically designed for an amyloidosis network. Amyloid. 2011;18(Suppl. 1):236-8.
Mass spectrometry-based proteomics as a diagnostic tool when immunoelectron microscopy fails in typing amyloid deposits. Amyloid. 2011;18(Suppl. 1):64-6.
The role of minor salivary gland biopsy in the diagnosis of systemic amyloidosis: results of a prospective study in 62 patients. Amyloid. 2011;18(Suppl. 1):80-2.
A workflow management system for the biological samples exchange within the amyloidosis network. Amyloid. 2011;18(Suppl. 1):233-5.
AMIloidosi CArtella (AMICA): an electronic patient record specifically designed for an amyloidosis network. In: Amyloid. Vol 17.; 2010. 88. (XII International Symposium on Amyloidosis; vol 17; no s1).
AMOnto: an ontology-based service for the AMICA project. In: Amyloid. Vol 17.; 2010. p. 142-3. (XII International Symposium on Amyloidosis; vol 17; no s1).
Knowledge management for clinical decision support in amyloidosis. In: Amyloid. Vol 17.; 2010. p. 141-2. (XII International Symposium on Amyloidosis; vol 17; no s1).
A Workflow Management System for the biological samples exchange within the amyloidosis network. Amyloid. 2010;17(s1):143-4.
Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide. Annals of Hematology. 2009;88(4):347-50.
AL Amyloidosis Associated with IgM Monoclonal Protein: A Distinct Clinical Entity. Clinical Lymphoma and Myeloma. 2009;9(1):80-3.
Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine. Clinical Chemistry. 2009;55(3):499-504.